Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation
Saulite I, Bobrowicz M, Hoetzenecker W, Pascolo S, Scarisbrick J, Dummer R, Cozzio A, Nägeli M, Anzengruber F, Varypataki E, Dimitriou F, Fassnacht C, Chang Y, Desislava I, Guenova E. Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation. Oncoimmunology 2020; 9:1738797.
18.03.2020
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation
18.03.2020
Oncoimmunology 2020; 9:1738797
Saulite Ieva, Bobrowicz Malgorzata, Hoetzenecker Wolfram, Pascolo Steve, Scarisbrick Julia, Dummer Reinhard, Cozzio Antonio, Nägeli Mirjam, Anzengruber Florian, Varypataki Eleni, Dimitriou Florentia, Fassnacht Christina, Chang Yun-Tsan, Desislava Ignatova, Guenova Emmanuella
Weiter
